BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator

Actinogen Medical Limited (ASX: ACW) has announced that the World Health Organization (WHO) has granted the nonproprietary name ‘emestedastat...

February 06, 2025 | News

Argent BioPharma’s CannEpil® Offers New Hope for Drug-Resistant Epilepsy Patients

Argent BioPharma Limited (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company, is pioneering a transformative approach to drug-resistant e...

February 06, 2025 | News

Kazia Therapeutics Launches Clinical Trial for Paxalisib-Immunotherapy Combination in Advanced Breast Cancer

Kazia Therapeutics Limited an oncology-focused drug development company, is pleased to announce the regulatory approval and launch of a clinical trial eval...

January 31, 2025 | News

Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform

Telix Pharmaceuticals Limited announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition inclu...

January 31, 2025 | News

Ryght AI and Cancer Research South Australia Partner to Accelerate Cancer Clinical Trials in Australia with AI

Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier...

January 29, 2025 | News

Australia’s Inventia Life Science Launches RASTRUM™ Allegro to Transform 3D Cell Culture Research

Inventia Life Science has announced the release of RASTRUM™ Allegro, a new development in 3D cell culture technology aimed at addressing challenges i...

January 28, 2025 | News

Telix Pharmaceuticals Completes Acquisition of RLS Radiopharmacies to Strengthen U.S. Radiopharmaceutical Footprint

Telix Pharmaceuticals Limited announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America's only Joint Commission-accr...

January 28, 2025 | News

Clarity Pharmaceuticals Secures Second FDA Fast Track Designation for 64Cu-SAR-bisPSMA in Prostate Cancer Imaging

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation product...

January 27, 2025 | News

Pearl Partners with Australia’s Centaur to Advance Dental AI Across Asia Pacific and Middle East

Pearl, the global leader in dental AI solutions, announced a strategic partnership with Centaur, Australia’s leading dental practice management ...

January 22, 2025 | News

Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma

Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

January 21, 2025 | News

Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmaceuticals

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, "Telix" or "the Company") today announced the acquisition of a next-generation therapeutics pipeline ...

January 13, 2025 | News